J&J's single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection

J&J's single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection

Business Insider

Published

J&J's shot was more effective among volunteers in the US than in Latin America and South Africa, where new strains are circulating.

Full Article